2h
Zacks Investment Research on MSNReasons to Retain Penumbra Stock in Your Portfolio for NowPenumbra, Inc.’s PEN thrombectomy business is thriving, driven by growing sales of the U.S. vascular thrombectomy and CAVT (computer-assisted vacuum thrombectomy) line of products. The company’s ...
Hosted on MSN1y
Here's Why You Should Retain Penumbra (PEN) Stock for Nowwith RED 72 with SENDit technology continuing to set the standard for the market in aspiration catheters and laying the groundwork for Thunderbolt. Global Expansion Continues: Penumbra derives a ...
Penumbra's shares have surged again on renewed ... the former designed for modulated aspiration in the venous anatomy and the latter meant for arteries below the knee. Bigger still should be ...
Equities researchers at William Blair reduced their Q1 2025 EPS estimates for shares of Penumbra in a research report issued ...
Penumbra, Inc. has a 12 month low of $148.00 ... The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results